Mai Capital Management Novo Nordisk A S Transaction History

Mai Capital Management

$10.1 Billion
Q3 2024

A detailed history of Mai Capital Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Mai Capital Management holds 28,958 shares of NVO stock, worth $2.46 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

28,958

Previous 48,667 40.5%

Holding current value

$2.46 Million

Previous $6.95 Million 50.36%

% of portfolio

0.03%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$119.07 - $145.42 $2.35 Million - $2.87 Million	-19,709 Reduced 40.5%	28,958 $3.45 Million
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $202,962 - $242,989	-1,654 Reduced 3.29%	48,667 $6.95 Million
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $1.73 Million - $2.31 Million	16,975 Added 50.91%	50,321 $6.46 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $221,820 - $266,472	2,527 Added 8.2%	33,346 $3.45 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.4 Million - $3.07 Million	15,361 Added 99.37%	30,819 $2.8 Million
Q2 2023 Aug 02, 2023	BUY	$155.98 - $172.65 $771,009 - $853,408	4,943 Added 47.01%	15,458 $2.5 Million
Q1 2023 May 10, 2023	BUY	$132.34 - $159.14 $112,753 - $135,587	852 Added 8.82%	10,515 $1.67 Million
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $58,248 - $76,867	568 Added 6.25%	9,663 $1.31 Million
Q3 2022 Nov 15, 2022	SELL	$95.28 - $116.93 $565,867 - $694,447	-5,939 Reduced 39.5%	9,095 $906,000
Q2 2022 Jul 19, 2022	BUY	$103.24 - $121.81 $152,898 - $180,400	1,481 Added 10.93%	15,034 $1.68 Million
Q1 2022 May 10, 2022	SELL	$93.1 - $112.54 $30,629 - $37,025	-329 Reduced 2.37%	13,553 $1.51 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $177,090 - $216,246	-1,847 Reduced 11.74%	13,882 $1.56 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $26,929 - $34,011	319 Added 2.07%	15,729 $1.51 Million
Q2 2021 Jul 19, 2021	SELL	$67.66 - $84.76 $3,788 - $4,746	-56 Reduced 0.36%	15,410 $1.29 Million
Q1 2021 May 10, 2021	BUY	$67.06 - $75.82 $203,594 - $230,189	3,036 Added 24.42%	15,466 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $8,369 - $9,667	-131 Reduced 1.04%	12,430 $868,000
Q3 2020 Oct 26, 2020	BUY	$63.69 - $70.22 $51,907 - $57,229	815 Added 6.94%	12,561 $872,000
Q2 2020 Jul 27, 2020	SELL	$58.54 - $67.94 $34,538 - $40,084	-590 Reduced 4.78%	11,746 $769,000
Q1 2020 Apr 16, 2020	SELL	$49.46 - $64.78 $89,028 - $116,604	-1,800 Reduced 12.73%	12,336 $743,000
Q4 2019 Feb 03, 2020	BUY	$49.86 - $58.26 $471,575 - $551,023	9,458 Added 202.18%	14,136 $818,000
Q2 2019 Aug 15, 2019	BUY	$46.79 - $52.47 $218,883 - $245,454	4,678 New	4,678 $239,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Novo Nordisk A S Transaction History